Advisory Board
Clinical Insight. Strategic Oversight. Responsible Innovation.
Alexander International Innovations is supported by a multidisciplinary advisory board comprised of experienced professionals across veterinary medicine, human infusion practice, healthcare operations, regulatory strategy, and commercialization.
I2F technology was designed to support safe, efficient medication preparation across both veterinary and human healthcare environments. Our advisory board provides strategic guidance to ensure thoughtful execution, responsible growth, and clinical relevance across markets.
Areas of Advisory Expertise
• Veterinary Clinical Practice & Hospital Operations
• Human Infusion Workflow & Patient Safety
• Regulatory & Compliance Strategy
• Healthcare Systems & Process Improvement
• Commercialization & Market Expansion
• Strategic Partnerships & Industry Engagement
Our advisory board reflects a commitment to multidisciplinary collaboration, ensuring that innovation is guided by clinical expertise, operational insight, regulatory discipline, and patient perspective.
Leadership
Damea Alexander
Damea founded Alexander International Innovations to address preventable inefficiencies and safety risks in medication preparation. As the inventor of I2F technology, he leads product strategy, commercialization, and regulatory expansion across both veterinary and human healthcare markets.
With a background in clinical research and healthcare operations, Damea brings a systems-level perspective to drug-delivery innovation.
On the Advisory Board, Damea provides strategic direction across product development, market expansion, and long-term platform growth.
Founder & Chief Executive Officer
Medical Device Innovator & Strategic Vision Lead
Jaime Pickett, DVM, MBA
Dr. Jaime Pickett brings extensive experience in veterinary clinical practice and hospital operations. Her expertise spans medication handling workflows, clinical standards, and practice-level implementation strategies.
As Chief Veterinary Officer, Dr. Pickett ensures that I2F technology integrates seamlessly into veterinary settings while maintaining the highest standards of patient safety and operational efficiency.
On the Advisory Board, she provides guidance on clinical application, workflow optimization, and real-world adoption across veterinary environments.
Chief Veterinary Officer
Maeve E. O'Connor MD, FACAAI, FAAAAI, FACP
Dr. Maeve O’Connor contributes expertise in clinical standards, safety oversight, and healthcare systems strategy. Her perspective supports the responsible evolution of I2F technology across both veterinary and human infusion environments.
As Chief Medical Officer, Dr. O’Connor advises on clinical positioning, regulatory considerations, and long-term healthcare integration.
On the Advisory Board, she provides strategic insight into patient safety, clinical adoption, and expansion into broader healthcare markets.
Chief Medical Officer
Advisory Board Members
Michael K. Handley
Michael K. Handley is an experienced pharmaceutical executive with a background in corporate leadership, commercialization strategy, and healthcare innovation. He has held senior leadership roles within the biotech and pharmaceutical sector, guiding product development, regulatory strategy, and market expansion initiatives.
His experience navigating the intersection of drug development, regulatory pathways, and commercialization provides valuable insight as AII advances I2F technology across both veterinary and human healthcare markets.
On the Advisory Board, Michael advises on pharmaceutical partnerships, regulatory positioning, capital strategy, and long-term platform growth.
Pharmaceutical Strategy & Commercialization Advisor
Paula Burge brings experience in regulatory affairs and healthcare compliance, with expertise in navigating structured approval pathways and ensuring alignment with evolving regulatory standards. Her background supports responsible development and market entry planning within highly regulated healthcare environments.
With insight into regulatory positioning, documentation standards, and compliance strategy, Paula contributes guidance as AII advances I2F technology across veterinary and human healthcare sectors.
On the Advisory Board, Paula advises on regulatory alignment, risk mitigation, and strategic planning to support sustainable and compliant growth.
Regulatory Affairs & Compliance Strategy Advisor
Paula Burge
Elena Kline PharmD, BCGP, BCACP
Dr. Kline is a board-certified clinical pharmacist with expertise in medication management, polypharmacy optimization, and patient-centered therapeutic oversight. Her experience spans direct patient care, medication safety practices, and interdisciplinary collaboration within healthcare settings.
With deep knowledge of drug preparation workflows and pharmacologic stability considerations, Dr. Kline provides valuable insight into medication handling processes and clinical risk mitigation.
On the Advisory Board, Dr. Kline advises on pharmacy workflow integration, medication safety standards, and real-world clinical adoption across both veterinary and human healthcare environments.
Clinical Pharmacy & Medication Safety Advisor
Jordan VanName RN BSN
Jordan brings experience in healthcare operations and frontline clinical environments, with a focus on workflow optimization, team coordination, and process improvement. Her background provides practical insight into how new technologies are adopted within real-world healthcare settings.
With a systems-oriented perspective, Jordan contributes to discussions surrounding implementation strategy, operational scalability, and user experience within human healthcare environments.
On the Advisory Board, Jordan provides guidance on workflow integration, operational efficiency, and adoption strategy across evolving care settings.
Healthcare Operations & Clinical Integration Advisor
Tori Finnerty
Tori Finnerty brings experience in infusion practice and patient-centered clinical care. Her background provides direct insight into medication preparation workflows, infusion safety considerations, and the operational demands of modern healthcare environments.
With a frontline perspective on patient safety, workflow efficiency, and care delivery, Tori contributes valuable guidance as I2F technology expands into broader infusion settings.
On the Advisory Board, Tori advises on infusion workflow alignment, clinical adoption strategy, and patient-centered implementation across care environments.
Infusion Nursing & Clinical Practice Advisor
Jason Epstein, DVM
Dr. Epstein is currently the Chief Veterinary Officer of CatsOnly Veterinary Services with experience in clinical medicine, hospital operations, and practice leadership. His perspective reflects the realities of modern veterinary workflows, medication preparation processes, and patient safety considerations within busy clinical environments.
With direct insight into frontline veterinary operations, Dr. Epstein contributes practical guidance on implementation, clinical adoption, and workflow efficiency as I2F technology expands across care settings.
On the Advisory Board, Dr. Epstein advises on veterinary integration strategy, clinical relevance, and practice-level execution.
Veterinary Clinical Strategy & Practice Leadership Advisor
Lauren Pastewka, DVM
Dr. Pastewka is a practicing veterinarian with experience in clinical medicine and patient care within modern veterinary environments. Her perspective reflects the realities of medication preparation, workflow efficiency, and safety considerations in day-to-day practice.
With firsthand insight into hospital operations and clinical execution, Dr. Pastewka contributes practical guidance on product integration, staff adoption, and maintaining high standards of care as new technologies are introduced.
On the Advisory Board, Dr. Pastewka advises on veterinary workflow alignment, medication handling practices, and clinical implementation strategy.
Veterinary Clinical Practice & Medication Safety Advisor
Elizabeth Reed, BS, LVT, CCRA
Elizabeth Reed brings experience in veterinary clinical practice and medication management systems, with a background that bridges hands-on patient care and structured medication control processes. Her expertise includes workflow optimization, regulatory awareness, and operational alignment within healthcare environments.
With insight into controlled substance handling and medication access systems, Elizabeth contributes practical guidance on integration, safety considerations, and adoption strategy.
On the Advisory Board, Elizabeth advises on medication management workflows, compliance alignment, and system integration considerations.
Medication Management & Clinical Workflow Advisor
Danijela Juric, LVT
Danijela Juric brings hands-on experience as a veterinary technician, with direct involvement in medication preparation, infusion setup, and day-to-day clinical workflows within veterinary practice. Her perspective reflects the operational realities faced by frontline clinical teams.
With practical insight into efficiency, safety considerations, and staff adoption dynamics, Danijela contributes valuable guidance on real-world integration of I2F technology.
On the Advisory Board, Danijela advises on technician workflow alignment, medication handling practices, and implementation strategy within veterinary care environments.
Veterinary Clinical Workflow & Technician Practice Advisor
Sean LeFever
Sean LeFever brings the lived perspective of a long-term IVIG patient, offering valuable insight into the realities of infusion therapy from the patient’s point of view. His experience navigating infusion workflows, medication preparation processes, and care environments provides an essential human lens to product development and implementation strategy.
Sean contributes perspective on patient comfort, safety considerations, and the broader impact of infusion practices on quality of life.
On the Advisory Board, Sean advises on patient-centered design, infusion experience considerations, and the practical realities of long-term therapy management.